Simone Schierle
Frankfurt Am Main, HE 60438, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor Agonists.
Journal: International journal of molecular sciences
Published: August 22, 2022
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors.
Journal: Journal of medicinal chemistry
Published: November 24, 2021
Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1.
Journal: Journal of medicinal chemistry
Published: October 11, 2021
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics.
Journal: Journal of medicinal chemistry
Published: April 01, 2021
Development and in vitro Profiling of Dual FXR/LTA4H Modulators.
Journal: ChemMedChem
Published: February 16, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist Switch.
Journal: ACS medicinal chemistry letters
Published: December 11, 2020
Design and Structural Optimization of Dual FXR/PPARδ Activators.
Journal: Journal of medicinal chemistry
Published: July 21, 2020
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice.
Journal: Communications chemistry
Published: May 04, 2020
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding Mode.
Journal: Journal of medicinal chemistry
Published: April 09, 2020
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast.
Journal: ChemMedChem
Published: October 15, 2019
Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.
Journal: Expert opinion on therapeutic patents
Published: July 13, 2019
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.
Journal: ACS medicinal chemistry letters
Published: July 08, 2019
Last Updated: 09/26/2026